U.S. Court of Appeals for the Federal Circuit
Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc.
This writing
- Type
- Opinion
- Filed
- July 31, 2020
- Case
- Takeda Pharmaceuticals U.S.A. v. Mylan Pharmaceuticals Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 20-1407 Document: 96 Page: 1 Filed: 07/31/2020 United States Court of Appeals for the Federal Circuit ______________________ TAKEDA PHARMACEUTICALS U.S.A., INC., Plaintiff-Appellant v. MYLAN PHARMACEUTICALS INC., Defendant-Appellee ______________________ 2020-1407, 2020-1417 ______________________ Appeal…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.